Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
phenotype | 0.100 | None | 0.985 | 67 | 0 | 2007 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.985 | 67 | 0 | 1996 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
phenotype | 0.100 | None | 0.925 | 67 | 0 | 1995 | 2019 | ||||||||
|
tumor protein p73 | 0.449 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.923 | 65 | 0 | 1997 | 2018 | ||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
phenotype | 0.100 | None | 0.938 | 64 | 0 | 2007 | 2020 | |||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.984 | 63 | 0 | 2000 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.100 | None | 0.935 | 62 | 0 | 2001 | 2020 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 0.984 | 62 | 0 | 1998 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
phenotype | 0.100 | None | 0.967 | 61 | 0 | 2001 | 2020 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
phenotype | 0.100 | None | 0.983 | 59 | 0 | 2002 | 2020 | ||||||||
|
UV radiation resistance associated | 0.436 | 0.769 | 0.99 |
|
phenotype | 0.100 | None | 0.897 | 58 | 0 | 1999 | 2019 | ||||||||
|
Rho GTPase activating protein 24 | 0.456 | 0.808 | 3.9E-10 |
|
phenotype | 0.100 | None | 0.914 | 58 | 0 | 1997 | 2018 | ||||||||
|
cytoskeleton associated protein 4 | 0.436 | 0.731 | 0.51 |
|
phenotype | 0.100 | None | 0.906 | 53 | 0 | 1999 | 2019 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
phenotype | 0.100 | None | 0.981 | 53 | 0 | 2003 | 2019 | ||||||||
|
retinoid isomerohydrolase RPE65 | 0.417 | 0.808 | 6.5E-14 |
|
phenotype | 0.100 | None | 0.906 | 53 | 0 | 1999 | 2019 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
phenotype | 0.100 | None | 1.000 | 53 | 0 | 1996 | 2020 | ||||||||
|
pyruvate kinase M1/2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 0.962 | 52 | 0 | 2010 | 2020 | ||||||||
|
Kruppel like factor 4 | 0.449 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 51 | 0 | 2003 | 2019 | ||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
phenotype | 0.100 | None | 0.939 | 49 | 0 | 2006 | 2019 | |||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.979 | 48 | 0 | 1999 | 2020 | ||||||||
|
neurofibromin 2 | 0.468 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.958 | 48 | 0 | 1994 | 2020 | ||||||||
|
H3 histone pseudogene 23 | 0.443 | 0.769 |
|
phenotype | 0.100 | None | 0.957 | 47 | 0 | 1995 | 2019 | |||||||||
|
eukaryotic translation initiation factor 4E | 0.448 | 0.846 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 47 | 0 | 1999 | 2020 | ||||||||
|
interferon alpha inducible protein 27 | 0.437 | 0.769 | 1.1E-02 |
|
phenotype | 0.100 | None | 0.957 | 47 | 0 | 1995 | 2019 | ||||||||
|
toll like receptor adaptor molecule 2 | 0.438 | 0.769 | 2.6E-03 |
|
phenotype | 0.100 | None | 0.957 | 47 | 0 | 1995 | 2019 |